Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$167,884,683
+$13,275,734 QoQ
Shares Held
1,204,597
-4.4% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026VAN ECK ASSOCIATES CORP holds $2,742,510,249 across 15 Drug Manufacturers - General names. GILD ranks #7 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
10,257,215 | $622,100,088 | |
| 2 | PFE |
Pfizer Inc
|
16,301,030 | $457,732,922 | |
| 3 | LLY |
ELI LILLY & Co
|
439,012 | $403,790,067 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,792,705 | $215,644,484 | |
| 5 | BIIB |
Biogen Inc.
|
1,079,861 | $197,970,916 | |
| 6 | JNJ |
Johnson & Johnson
|
736,828 | $180,110,235 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
1,204,597 | $167,884,683 | |
| 8 | NVS |
Novartis AG
|
891,803 | $136,222,908 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $167,884,683 | 1,204,597 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $154,608,949 | 1,259,646 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $139,751,442 | 1,259,022 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $140,137,794 | 1,263,983 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $380,496,588 | 3,395,775 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $565,606,357 | 6,123,269 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $531,782,950 | 6,342,831 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $433,614,101 | 6,319,984 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $408,160,207 | 5,572,153 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $404,435,539 | 4,992,415 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $339,840,834 | 4,534,839 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $295,370,543 | 3,832,497 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $165,957,008 | 2,000,205 | Shares | Defined | 2023-05-03 | |
| 2022-12-31 | $170,147,659 | 1,981,918 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $225,970,901 | 3,663,007 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $239,183,065 | 3,869,650 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $211,517,986 | 3,557,914 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $241,159,809 | 3,321,303 | Shares | Defined | 2022-01-26 | |
| 2021-09-30 | $221,543,873 | 3,171,709 | Shares | Defined | 2021-11-03 | |
| 2021-06-30 | $204,062,684 | 2,963,443 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $165,432,570 | 2,559,687 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $129,153,156 | 2,216,841 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $119,084,904 | 1,884,553 | Shares | Defined | 2020-12-04 | |
| 2020-06-30 | $135,331,535 | 1,758,923 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $117,882,838 | 1,576,817 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||